Guardion Health Sciences, Inc. (GHSI)
| Previous close | 7.90 |
| Open | 8.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 8.00 - 8.00 |
| 52-week range | 5.01 - 10.75 |
| Volume | |
| Avg. volume | 21,386 |
| Market cap | 10.273M |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | 66.67 |
| EPS (TTM) | 0.12 |
| Earnings date | 13 May 2024 - 17 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 40.00 |
Simply Wall St.Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching
While Guardion Health Sciences, Inc. ( NASDAQ:GHSI ) might not have the largest market cap around , it saw a...
GlobeNewswireGuardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
Viactiv® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022 HOUSTON, TEXAS, March 29, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals
- GlobeNewswire
Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.
HOUSTON, TEXAS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) announced today that it has signed an equity purchase agreement to sell its Activ Nutritional, LLC subsidiary, which owns the Viactiv® brand and business, to Doctor’s Best Inc. (“Doctor’s Best”), a wholly-owned subsidiary of Kingdomway USA Corp. (“Kingdomway”), for gross cash consideration of $17.2 million, payable in full at closing. The transaction has been approved by
